Latest period
$10.33B
YoY change
+3.4%
5Y CAGR
+17.7%
Peak year (2025)
$10.34B
Latest annual
$10.34B
Total Equity history chart for Edwards Lifesciences (EW) from 1999 to 2025
Latest: $10.34B
Total Equity growth chart for Edwards Lifesciences (EW) from 1999 to 2025
Latest: +3.4%
Total Equity history table for Edwards Lifesciences (EW) from 1999 to 2025
| 2025 | $10.34B | +3.4% | +$339.20M | ||
| 2024 | $10.00B | +50.4% | +$3.35B | ||
| 2023 | $6.65B | +14.5% | +$843.30M | ||
| 2022 | $5.81B | -0.5% | −$29.20M | ||
| 2021 | $5.84B | +27.6% | +$1.26B | ||
| 2020 | $4.57B | +10.3% | +$426.00M | ||
| 2019 | $4.15B | +32.1% | +$1.01B | ||
| 2018 | $3.14B | +4.9% | +$145.70M | ||
| 2017 | $2.99B | +14.3% | +$375.70M | ||
| 2016 | $2.62B | +4.6% | +$115.90M | ||
| 2015 | $2.50B | +14.2% | +$311.70M | ||
| 2014 | $2.19B | +40.5% | +$632.20M | ||
| 2013 | $1.56B | +5.4% | +$79.90M | ||
| 2012 | $1.48B | +10.6% | +$141.40M | ||
| 2011 | $1.34B | +2.3% | +$29.70M | ||
| 2010 | $1.31B | +13.0% | +$150.30M | ||
| 2009 | $1.16B | +31.8% | +$279.10M | ||
| 2008 | $878.80M | +5.2% | +$43.80M | ||
| 2007 | $835.00M | +11.4% | +$85.60M | ||
| 2006 | $749.40M | +8.6% | +$59.40M | ||
| 2005 | $690.00M | +9.9% | +$61.90M | ||
| 2004 | $628.10M | -1.1% | −$7.00M | ||
| 2003 | $635.10M | +17.7% | +$95.70M | ||
| 2002 | $539.40M | +17.5% | +$80.40M | ||
| 2001 | $459.00M | +4.3% | +$19.00M | ||
| 2000 | $440.00M | -64.1% | −$784.00M | ||
| 1999 | $1.22B | — | — |
- 2025$10.34B+3.4%
- 2024$10.00B+50.4%
- 2023$6.65B+14.5%
- 2022$5.81B-0.5%
- 2021$5.84B+27.6%
- 2020$4.57B+10.3%
- 2019$4.15B+32.1%
- 2018$3.14B+4.9%
- 2017$2.99B+14.3%
- 2016$2.62B+4.6%
- 2015$2.50B+14.2%
- 2014$2.19B+40.5%
- 2013$1.56B+5.4%
- 2012$1.48B+10.6%
- 2011$1.34B+2.3%
- 2010$1.31B+13.0%
- 2009$1.16B+31.8%
- 2008$878.80M+5.2%
- 2007$835.00M+11.4%
- 2006$749.40M+8.6%
- 2005$690.00M+9.9%
- 2004$628.10M-1.1%
- 2003$635.10M+17.7%
- 2002$539.40M+17.5%
- 2001$459.00M+4.3%
- 2000$440.00M-64.1%
- 1999$1.22B—
Total Equity values are taken from Edwards Lifesciences's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Equity at Edwards Lifesciences (EW)
According to Edwards Lifesciences's latest reported financial statements, the company's latest reported total equity is $10.33B. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Edwards Lifesciences (EW) total equity is $10.34B – edged up 3.4% year-over-year.
Over 2020–2025 (5 years), Edwards Lifesciences total equity expanded at a +17.7% compound annual rate, sustaining 3 straight years of year-over-year growth.
$10.34B stands as the all-time-high annual total equity, posted in 2025, against a low of $440.00M during 2000.
Edwards Lifesciences Total Equity by Year
Edwards Lifesciences Total Equity 2025: $10.34B
Edwards Lifesciences posted total equity of $10.34B in 2025, edged up 3.4% from 2024. This figure represents the highest annual value in the available history.
Edwards Lifesciences Total Equity 2024: $10.00B
In 2024, Edwards Lifesciences reported total equity of $10.00B, surged 50.4% from 2023.
Edwards Lifesciences Total Equity 2023: $6.65B
Edwards Lifesciences total equity in 2023 was $6.65B, grew 14.5% from 2022.
Edwards Lifesciences Total Equity 2022: $5.81B
2022's total equity for Edwards Lifesciences came in at $5.81B, edged down 0.5% below 2021.
Edwards Lifesciences Total Equity 2021: $5.84B
Edwards Lifesciences total equity in 2021 was $5.84B.
See more financial history for Edwards Lifesciences (EW).
Sector peers by Total Equity
Healthcare peers of Edwards Lifesciences (EW), ranked by their latest total equity
| $94.11B | |
| $81.54B | |
| $52.61B | |
| $48.67B | |
| $30.52B | |
| $26.54B | |
| $8.66B | |
| −$3.27B |
- $94.11B
- $81.54B
- $52.61B
- $48.67B
- $30.52B
- $26.54B
- $8.66B
- −$3.27B
Frequently asked questions
Edwards Lifesciences (EW) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation